These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33600451)
41. Geographic patterns and environmental factors associated with human yellow fever presence in the Americas. Hamrick PN; Aldighieri S; Machado G; Leonel DG; Vilca LM; Uriona S; Schneider MC PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005897. PubMed ID: 28886023 [TBL] [Abstract][Full Text] [Related]
42. Late or Lack of Vaccination Linked to Importation of Yellow Fever from Angola to China. Song R; Guan S; Lee SS; Chen Z; Chen C; Han L; Xu Y; Li A; Zeng H; Ye H; Zhang F Emerg Infect Dis; 2018 Jul; 24(7):1383-6. PubMed ID: 29723485 [TBL] [Abstract][Full Text] [Related]
43. The global burden of yellow fever. Gaythorpe KA; Hamlet A; Jean K; Garkauskas Ramos D; Cibrelus L; Garske T; Ferguson N Elife; 2021 Mar; 10():. PubMed ID: 33722340 [TBL] [Abstract][Full Text] [Related]
45. The second coming of urban yellow fever in the Americas: looking the past to see the future. Salomón OD; Arias AR An Acad Bras Cienc; 2022; 94(2):e20201252. PubMed ID: 35730861 [TBL] [Abstract][Full Text] [Related]
46. 14 million people in central Africa to be vaccinated to try to halt yellow fever outbreak. Gulland A BMJ; 2016 Aug; 354():i4559. PubMed ID: 27535301 [No Abstract] [Full Text] [Related]
47. Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study. Kraemer MUG; Faria NR; Reiner RC; Golding N; Nikolay B; Stasse S; Johansson MA; Salje H; Faye O; Wint GRW; Niedrig M; Shearer FM; Hill SC; Thompson RN; Bisanzio D; Taveira N; Nax HH; Pradelski BSR; Nsoesie EO; Murphy NR; Bogoch II; Khan K; Brownstein JS; Tatem AJ; de Oliveira T; Smith DL; Sall AA; Pybus OG; Hay SI; Cauchemez S Lancet Infect Dis; 2017 Mar; 17(3):330-338. PubMed ID: 28017559 [TBL] [Abstract][Full Text] [Related]
48. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination. Adu FD; Adeniji JA; Tomori O; Adelasoye A Rom J Virol; 1993; 44(1-2):3-7. PubMed ID: 9702244 [TBL] [Abstract][Full Text] [Related]
49. Yellow fever in the diagnostics laboratory. Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363 [TBL] [Abstract][Full Text] [Related]
50. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination. Adu FD; Adeniji JA; Tomori O; Adelasoye A Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476 [TBL] [Abstract][Full Text] [Related]
54. Yellow fever in Africa and South America, 2015. Wkly Epidemiol Rec; 2016 Aug; 91(32):381-8. PubMed ID: 27522678 [No Abstract] [Full Text] [Related]
55. Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso. Pfeiffer G; Fisker AB; Nebié E; Hengelbrock J; Sié A; Becher H; Müller O Vaccine; 2017 Dec; 35(51):7114-7120. PubMed ID: 29153586 [TBL] [Abstract][Full Text] [Related]
57. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages. Chen LH; Kozarsky PE; Visser LG Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852 [TBL] [Abstract][Full Text] [Related]
58. The incidence and mortality of yellow fever in Africa: a systematic review and meta-analysis. Nwaiwu AU; Musekiwa A; Tamuzi JL; Sambala EZ; Nyasulu PS BMC Infect Dis; 2021 Oct; 21(1):1089. PubMed ID: 34688249 [TBL] [Abstract][Full Text] [Related]
59. [Yellow fever prevention and control: assessment of surveillance activities in a previously unaffected area in Brazil]. Gava C; Silva TCCD; Lyra DGP; Ardisson KS; Marques CS; Almada GL; Corrêa LMC; Siqueira PC; Rodrigues GAP; Moura L; Cruz OG; Maciel ELN; Camacho LAB Cad Saude Publica; 2022; 38(1):e00000521. PubMed ID: 35081199 [TBL] [Abstract][Full Text] [Related]